Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Notes Payables: 2016-2017

Historic Notes Payables for Editas Medicine (EDIT) over the last 1 years, with Dec 2017 value amounting to $7.5 million.

  • Editas Medicine's Notes Payables fell 25.00% to $7.5 million in Q4 2017 from the same period last year, while for Dec 2017 it was $7.5 million, marking a year-over-year decrease of 25.00%. This contributed to the annual value of $7.5 million for FY2017, which is 25.00% down from last year.
  • Editas Medicine's Notes Payables amounted to $7.5 million in Q4 2017, which was down 50.00% from $15.0 million recorded in Q2 2017.
  • Over the past 5 years, Editas Medicine's Notes Payables peaked at $15.0 million during Q1 2017, and registered a low of $7.5 million during Q4 2017.
  • Its 2-year average for Notes Payables is $11.9 million, with a median of $12.5 million in 2016.
  • Data for Editas Medicine's Notes Payables shows a maximum YoY fell of 25.00% (in 2017) over the last 5 years.
  • Quarterly analysis of 2 years shows Editas Medicine's Notes Payables stood at $10.0 million in 2016, then declined by 25.00% to $7.5 million in 2017.
  • Its last three reported values are $7.5 million in Q4 2017, $15.0 million for Q2 2017, and $15.0 million during Q1 2017.